Cost based pricing for innovative medicines Is unviable and harmful

12 April 2024 - Barber et al. just published a fundamentally flawed study on diabetes medicines in JAMA Network Open.  ...

Read more →

Medicare drug price negotiations: policy implications of the first 10 drugs’ features

9 April 2024 - This article describes how CMS’s approach to implementing the negotiations will be shaped by the distinctive ...

Read more →

ICER publishes 2024 research protocol for assessing unsupported price increases on prescription drugs

9 April 2024 - Input period now open until 13 May 2024. ...

Read more →

Net prices for medicines fell considerably in 2023’s last quarter, mostly thanks to Humira biosimilars

1 April 2024 - The net prices that health plans paid for medicines — after subtracting rebates, discounts, and fees ...

Read more →

Joe Biden’s assault on the $900 child eczema cream

2 April 2024 - What the Inflation Reduction Act means for the cost of health care. ...

Read more →

AstraZeneca caps patient out of pocket costs at $35 per month for its US inhaled respiratory portfolio

18 March 2024 - Expanded savings programs build on company’s longstanding commitment to addressing barriers to access and affordability for ...

Read more →

Boehringer Ingelheim caps patient out of pocket costs for its inhaler portfolio at $35 per month

7 March 2024 - Boehringer makes significant investment to improve the affordability of and access to its full range of inhaler ...

Read more →

Biden says Medicare should negotiate prices for at least 50 drugs each year, up from a target of 20

6 March 2024 - That proposal is one of several new health care policy plans Biden will outline during his State ...

Read more →

Early impact of the Inflation Reduction Act on drug discovery

6 March 2024 - Despite the concerns of the biopharma industry, the Inflation Reduction Act has been enacted and with it, ...

Read more →

Drug makers send counter offers for US Medicare price negotiations, Biden says

4 March 2024 - The manufacturers of 10 high cost drugs selected for the US Medicare program's first-ever pricing negotiations ...

Read more →

Federal judge rules against AstraZeneca in lawsuit challenging Medicare drug price negotiation

1 March 2024 - A federal judge in Delaware on Friday ruled against AstraZeneca in a case challenging the constitutionality ...

Read more →

Bernie Sanders wants to rein in drug prices. Is he asking the right questions?

28 February 2024 - We have a serious problem of affordability of health care in the US, including the cost of ...

Read more →

Prices for new US drugs rose 35% in 2023, more than the previous year

23 February 2024 - Pharmaceutical companies last year launched new US drugs at prices 35% higher than in 2022, reflecting ...

Read more →

Insulin prices were capped for millions. But many still struggle to afford to life-saving medication.

21 February 2024 - Insulin prices recently decreased for some of the estimated 8.4 million Americans who rely on the ...

Read more →

The Biden Administration versus Medicare Advantage

21 February 2024 - When does the failure to answer a phone call in 8 seconds cost the company receiving the ...

Read more →